Cutaneous angioimmunoblastic T-cell lymphoma: Epstein–Barr Virus positivity and its effects on clinicopathological features

1. Epstein–Barr virus in situ hybridization is positive in 19 of 42 (45.2%) patients with cutaneous angioimmunoblastic T-cell lymphoma. 2. Epstein–Barr virus-positive cutaneous angioimmunoblastic T-cell lymphoma is associated with distinctive clinicopathological features but shows no significant differences in survivals compared to Epstein–Barr virus-negative cutaneous angioimmunoblastic T-cell lymphoma.